Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 22, 2015 5:42 AM ET


Company Overview of Andrx Corporation

Company Overview

Andrx Corporation is a holding company which through its subsidiaries develops, manufactures, commercializes, and distributes generic versions of controlled-release pharmaceuticals, oral contraceptives, and generic versions of immediate-release products. The company also develops and commercializes brand name pharmaceuticals; and distributes primarily generics that are commercialized by others and its own products. In addition, it offers contract services such as development and manufacture of pharmaceutical products including combination products and controlled-release formulations for other pharmaceutical companies; and contract research and development services. It also markets generic pr...

4955 Orange Drive

Davie, FL 33314

United States

Founded in 1992

1,680 Employees





Key Executives for Andrx Corporation

Chief Information Officer, Senior Vice President and Head of Project Management Office
Age: 63
Executive Vice President of Commercial Development
Compensation as of Fiscal Year 2014.

Andrx Corporation Key Developments

Galena Biopharma's Partner Orexo Files Patent Infringement Suit Against Actavis Laboratories, Andrx Corporation, Actavis, Inc. and Actavis Pharma

Galena Biopharma (GALE) announced that its partner Orexo has filed a patent infringement lawsuit in United States District Court for the District of New Jersey, against Actavis Laboratories, Andrx Corporation, Actavis Inc. (ACT) and Actavis Pharma for seeking to market a generic version of its Abstral drug. The lawsuit was filed in response to an Abbreviated New Drug Application filed by Actavis. In its application, Actavis seeks to market and sell generic versions of Abstral sublingual tablets in the U.S. prior to the expiration of Orexo's U.S. patents.

Horizon Pharma, Inc. Files Suit in United States District Court for the District of New Jersey Against Watson Laboratories, Inc., Actavis Pharma, Inc., Andrx Corp., and Actavis, Inc

On August 26, 2013, Horizon Pharma, Inc. filed suit in the United States District Court for the District of New Jersey against Watson Laboratories, Inc. - Florida, Actavis Pharma, Inc., Andrx Corp., and Actavis, Inc. (collectively, WLF). The lawsuit alleges that WLF has infringed U.S. Patent Nos. 6,488,960, 6,677,326, 8,168,218, 8,309,124, and 8,394,407 by filing an Abbreviated New Drug Application (ANDA) seeking approval from the U.S. Food and Drug Administration (FDA) to market generic versions of RAYOS containing 1 mg, 2 mg, and 5 mg of prednisone prior to the expiration of the patents. The subject patents are listed in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book. Commencement of the patent infringement lawsuit stays, or bars, FDA approval of WLF's ANDA for 30 months or until an earlier district court decision that the subject patents are not infringed or invalid.

Similar Private Companies By Industry

Company Name Region
Meda Pharmaceuticals Inc. United States
Meridian Medical Technologies, Inc. United States
Bach Pharma, Inc. United States
Novita Pharmaceuticals, Inc. United States
INSMED Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Andrx Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at